KRSA

Korsana Biosciences, Inc.
NasdaqCMUSDEQUITY Healthcare DELAYED
Last price
31.77
▲ 1.05 (3.42%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
30.72
Day high
31.89
Day low
30.50
Volume
42.02K
Market cap
$1.45B
P/E (TTM)
—
52W range
7.19 – 59.36

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-6.56% -8.5%
1M
+6.79% +5.6%
3M
+30.61% +26.1%
6M
+30.42% +12.2%
YTD
+257.37% +243.1%
1Y
+81.54% +65.1%
3Y
+32.71% -49.5%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on KRSA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
+21.83M
Net buying
Buy transactions
39
22.27M shares
Sell transactions
9
443.76K shares
Net transactions
+48
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
20.52K
Total on file
Bought 22.27MSold 443.76K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 14, 26
CHICKO RHONDA M. CPA
Chief Financial Officer
CONVERSION 25.00K $58.88K Direct
Aug 14, 26
GRAUL REGINA MARGARET
Chief Executive Officer
CONVERSION 55.85K $184.30K Direct
Jul 16, 26
HECHT PETER M
Director and Beneficial Owner of more than 10% of a Class of Security
— 351.04K — Direct
Mar 25, 25
HECHT PETER M
Director and Beneficial Owner of more than 10% of a Class of Security
STOCK 181.82K $500.00K Direct
Mar 25, 25
HIGGINS MICHAEL J
Director
STOCK 9.09K $25.00K Direct
Nov 21, 24
SLATE PATH CAPITAL LP
Beneficial Owner of more than 10% of a Class of Security
SELL 357.88K $555.11K Indirect
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

5 reporting
NameRelationShares heldLatest
CHICKO RHONDA M. CPA
Chief Financial Officer 25.02K Conversion of Exercise of derivative security
GRAUL REGINA MARGARET
Chief Executive Officer 107.52K Conversion of Exercise of derivative security
HECHT PETER M
Director and Beneficial Owner of more than 10% of a Class of Security 910.31K Conversion of Exercise of derivative security
HIGGINS MICHAEL J
Director 30.74K Stock Award(Grant)
SLATE PATH CAPITAL LP
Beneficial Owner of more than 10% of a Class of Security — Sale

Fundamentals

TTM · reported
Market cap$1.45B
Enterprise value$233.09M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-49.08M
EPS (TTM)$-7.07
Free cash flow—
Total cash$134.16M
Total debt$1.10M
Book value / share$-7.84
Shares outstanding45.54M
Float4.31M
Short % of float—
Dividend yield0.00%
Beta (5Y)1.73

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E-8.93
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity—
Return on assets—
Debt / equity0.85
Current ratio17.40
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 2 years · 1 quarters
Blank means not reported, not zero
Line item20252024YoY
Total revenue $0$0 —
Operating revenue $0$0 —
Research & development $32.78M$56.00K +58,444.6%
Selling, general & admin $4.51M$53.00K +8,401.9%
Total operating expense $37.29M$109.00K +34,111.9%
Operating income -$37.29M-$109.00K -34,111.9%
Net interest income $1.65M$21.00K +7,752.4%
Pre-tax income -$35.64M-$88.00K -40,402.3%
Net income -$35.64M-$88.00K -40,402.3%
Net income to common -$35.64M-$88.00K -40,402.3%
Basic EPS —-0.02 —
Diluted EPS —-0.02 —
EBIT -$37.29M-$109.00K -34,111.9%
EBITDA -$37.29M-$109.00K -34,111.9%
Basic shares —5.04M —
Diluted shares —5.04M —

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Mar 2026 —-2.70 —
Dec 2025 -0.38-0.19 +50.0%
Sep 2025 —-0.30 —
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter — — $0 —
Next quarter -0.67 1 $0 —
Current year -1.70 1 $0 -100.0%
Next year -3.56 1 $0 0.0%

Analyst targets & ownership

Account required
Mean target$44.00
High target$70.00
Low target$8.00
Implied upside38.50%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy0 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders0.34%
Held by institutions30.13%
Institutions holding26
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
32.15
-1.18% from price
SMA 20
31.80
-0.09% from price
SMA 50
28.88
+10.01% from price
SMA 100
26.06
+21.93% from price
SMA 200
20.01
+58.78% from price
EMA 12
31.77
+0.01% from price
EMA 26
31.03
+2.39% from price
EMA 50
29.38
+8.14% from price
RSI (14)
51.7
Neutral
MACD (12,26,9)
0.74
Hist -0.42
ATR (14)
3.78
11.89% of price
Realised vol 30D
155.8%
Annualised
Bollinger upper
37.26
20, 2σ
Bollinger lower
26.34
20, 2σ
50 / 200 cross
Golden
28.88 vs 20.01
Trend bias
Above 200
+58.78%

Options chain

Account required
Expiry
Spot 31.77
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
2.20
More volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
155.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-57.6%
Peak to trough
Max drawdown 5Y
-98.2%
Peak to trough
ATR 14
3.78
11.89% of price
Beta (reported)
1.73
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
4.44K
Latest report
Change vs prior
—
—
% of float
—
—
% of shares out
0.01%
Against total outstanding
Days to cover
0.1
Liquid
Float
4.31M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

5 on file
DateFirm ActionFromTo
Oct 5, 26 Wedbush INITIATED — Outperform
Sep 28, 26 Guggenheim INITIATED — Buy
Sep 14, 26 Stifel INITIATED — Buy
Sep 14, 26 TD Cowen INITIATED — Buy
Sep 11, 26 UBS INITIATED — Buy

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:7
Split dateSep 9, 2026

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.